Pleural Effusion Size as Prognostic Marker in Patients With Malignant Pleural Effusion
PLEURA · 2015
DOI: 10.1177/2373997515600657 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLEURA, 2015. Verfasst von Felicia Montero-Arias und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
Inconsistent results have been reported regarding mortality predictors of malignant pleural effusion (MPE).
Objective
We aim to describe prognostic features of MPE in patients evaluated over 5 years in a referral center.
Methods
All consecutive MPEs (confirmed by pleural cytology or biopsy) from January 2009 to July 2014 were included in this retrospective cohort study. Clinical data were collected from medical registries. Overall survival (OS) rate was calculated with Kaplan-Meier method and compared by the log-rank test. Hazard ratios (HRs) were calculated by the Cox proportional regression model.
Results
A total of 110 patients were identified. Mean OS was 8.3 months (range: 25-426 days). No difference in OS was noted based on tumor type. Patients with MPE
Zitieren
APA
Montero-Arias, F., Cartin-Ceba, R., Rojas-Solano, J., Ugalde-Gamboa, L., & Ramos-Esquivel, A. (2015). Pleural Effusion Size as Prognostic Marker in Patients With Malignant Pleural Effusion. PLEURA. https://doi.org/10.1177/2373997515600657
Vancouver
Montero-Arias F, Cartin-Ceba R, Rojas-Solano J, Ugalde-Gamboa L, Ramos-Esquivel A. Pleural Effusion Size as Prognostic Marker in Patients With Malignant Pleural Effusion. PLEURA. 2015. doi:10.1177/2373997515600657
BibTeX
@article{MonteroArias2015,
author = {Montero-Arias, Felicia and Cartin-Ceba, Rodrigo and Rojas-Solano, Jose and Ugalde-Gamboa, Luis and Ramos-Esquivel, Allan},
title = {Pleural Effusion Size as Prognostic Marker in Patients With Malignant Pleural Effusion},
journal = {PLEURA},
year = {2015},
doi = {10.1177/2373997515600657}
}
EUVIMED